CLINICAL_TRIALS
trial_result
· 2018-12-26
Clinical Trial Update: The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU [Phase 4]
Summary
Clinical trial update about nalbuphine achieving 90% effective dose in mechanically ventilated ICU patients (Phase 4).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hua-Qing Shu | Conditions: Pain | Phase 4 | Status: UNKNOWN